Wild-type (senile) amyloidosis echocardiography and ultrasound: Difference between revisions
No edit summary |
No edit summary |
||
Line 20: | Line 20: | ||
| pmid = 29707360 | | pmid = 29707360 | ||
}}</ref> | }}</ref> | ||
*Other echocardiographic findings related to cardiac amyloidosis include: | |||
:*Diastolic dysfunction with preserved ejection fraction (hallmark)<ref>{{Cite journal | |||
| author = [[Wendy Tsang]] & [[Roberto M. Lang]] | |||
| title = Echocardiographic evaluation of cardiac amyloid | |||
| journal = [[Current cardiology reports]] | |||
| volume = 12 | |||
| issue = 3 | |||
| pages = 272–276 | |||
| year = 2010 | |||
| month = May | |||
| doi = 10.1007/s11886-010-0108-7 | |||
| pmid = 20424972 | |||
}}</ref><ref>{{Cite journal | |||
| author = [[Diego Bellavia]], [[Patricia A. Pellikka]], [[Theodore P. Abraham]], [[Ghormallah B. Al-Zahrani]], [[Angela Dispenzieri]], [[Jae K. Oh]], [[Kent R. Bailey]], [[Christina M. Wood]], [[Martha Q. Lacy]], [[Chinami Miyazaki]] & [[Fletcher A. Jr Miller]] | |||
| title = Evidence of impaired left ventricular systolic function by Doppler myocardial imaging in patients with systemic amyloidosis and no evidence of cardiac involvement by standard two-dimensional and Doppler echocardiography | |||
| journal = [[The American journal of cardiology]] | |||
| volume = 101 | |||
| issue = 7 | |||
| pages = 1039–1045 | |||
| year = 2008 | |||
| month = April | |||
| doi = 10.1016/j.amjcard.2007.11.047 | |||
| pmid = 18359328 | |||
}}</ref> | |||
:* | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} |
Revision as of 14:51, 19 December 2019
Wild-type (senile) amyloidosis Microchapters |
Differentiating Wild-type (senile) amyloidosis from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Wild-type (senile) amyloidosis echocardiography and ultrasound On the Web |
American Roentgen Ray Society Images of Wild-type (senile) amyloidosis echocardiography and ultrasound |
FDA on Wild-type (senile) amyloidosis echocardiography and ultrasound |
CDC on Wild-type (senile) amyloidosis echocardiography and ultrasound |
Wild-type (senile) amyloidosis echocardiography and ultrasound in the news |
Blogs on Wild-type (senile) amyloidosis echocardiography and ultrasound |
Risk calculators and risk factors for Wild-type (senile) amyloidosis echocardiography and ultrasound |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sabawoon Mirwais, M.B.B.S, M.D.[2]
Overview
Echocardiography/Ultrasound
Echocardiography
- Echocardiography is the most frequently used diagnostic modality for cardiomyopathy.
- The most commonly encountered pathology on 2D echocardiography is increased left ventricular thickness (secondary to amyloid fibrils deposition in the extracellular matrix).[1]
- Other echocardiographic findings related to cardiac amyloidosis include:
References
- ↑ Ilia G. Halatchev, Jingsheng Zheng & Jiafu Ou (2018). "Wild-type transthyretin cardiac amyloidosis (ATTRwt-CA), previously known as senile cardiac amyloidosis: clinical presentation, diagnosis, management and emerging therapies". Journal of thoracic disease. 10 (3): 2034–2045. doi:10.21037/jtd.2018.03.134. PMID 29707360. Unknown parameter
|month=
ignored (help) - ↑ Wendy Tsang & Roberto M. Lang (2010). "Echocardiographic evaluation of cardiac amyloid". Current cardiology reports. 12 (3): 272–276. doi:10.1007/s11886-010-0108-7. PMID 20424972. Unknown parameter
|month=
ignored (help) - ↑ Diego Bellavia, Patricia A. Pellikka, Theodore P. Abraham, Ghormallah B. Al-Zahrani, Angela Dispenzieri, Jae K. Oh, Kent R. Bailey, Christina M. Wood, Martha Q. Lacy, Chinami Miyazaki & Fletcher A. Jr Miller (2008). "Evidence of impaired left ventricular systolic function by Doppler myocardial imaging in patients with systemic amyloidosis and no evidence of cardiac involvement by standard two-dimensional and Doppler echocardiography". The American journal of cardiology. 101 (7): 1039–1045. doi:10.1016/j.amjcard.2007.11.047. PMID 18359328. Unknown parameter
|month=
ignored (help)